Communication is key to containing COVID miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
08-02-2021
Copyright: Dolyan Basko/Koverznev A.
Following an unprecedented year for WHO in 2020, WHO/Europe looks ahead to 2021 with a focus on the continuing COVID-19 pandemic alongside the implementation of the European Programme of Work.
With the ongoing roll-out of COVID-19 vaccines and WHO/Europe continuing to provide support in response to the pandemic, this area of work remains a priority. But alongside the pandemic, WHO/Europe offers support and expertise in a many areas to assist countries and partners in delivering health to everyone living in the WHO European Region.
This article highlights a select range of important milestones and upcoming events over the course of the year.
Population-level screening for cardiovascular disease (CVD) risk factors has no effect on lowering CVD morbidity and mortality, concludes a recently published WHO Health Evidence Network (HEN) report. To reduce CVD risks, which are also associated with poorer COVID-19 outcomes, the report proposes some alternative measures for consideration by policy-makers in the WHO European Region.
Reply
The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives. (Shutterstock)
LOS ANGELES, CA An international research team co-led by a UCLA Fielding School of Public Health professor found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications.
The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, according to Dr. Marc Suchard, a professor of biostatistics at the UCLA Fielding School.
If the coronavirus pandemic and Europe-wide lockdowns taught us one thing, it is just how
reliant we all are on digital technologies – including for our own health, and that data was in the right place at the right time to answer the right questions.
Nigel Hughes is Scientific Director at Jannsen Research and Development (Johnson & Johnson), a Corporate Knowledge Partner of All Policies for a Healthy Europe.
Digital health can have a transformational impact on the well-being of EU citizens: from telemedicine enabling safe remote treatment of patients, to health data access allowing tracking and treatment of diseases, and Artificial Intelligence enhancing clinical decision-making. In April 2018, a European Commission Communication on the Transformation of Digital Health and Care stated the following: “Digital solutions for health and care can increase the wellbeing of millions of citizens and radically change the way health and care services are delivered to patients, if desi